2022 annual financial data
Tvardi Therapeutics 2022 Operating margin
Tvardi Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -209.08%.
Operating income was -87,535,000 USD and net income was -85,474,000 USD.
Operating cash flow was -17,866,000 USD.
Get free Tvardi Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 41,867,000 USD
- Operating income
- -87,535,000 USD
- Net income
- -85,474,000 USD
- Operating cash flow
- -17,866,000 USD